News
CIIE's biomedicine zone attracts Zhangjiang enterprises Release date： 2021-03-24 Source：Multiple
Companies in Zhangjiang Science City, the heart of biomedicine in Shanghai, have shown great interest in the 4th CIIE's new biomedicine subsection, hoping to take the opportunity to widen their businesses.
"The subsection is a good chance for Zhangjiang to give full play to its innovative advantages in the life and health industry and to seek more global cooperation in life science," said Lou Qi, GM of Shanghai Zhangjiang Biotech & Pharmaceutical Base Development Co Ltd.
According to the China International Import Expo Bureau, the subsection welcomes exhibits ranging from biological products and new therapies such as vaccines, recombinant proteins, blood products, cell and gene therapy and tumor immunotherapy, to biological technology and R&D platform services, including enzyme engineering, biochip technology, gene sequencing technology and bioinformatics.
Zhangjiang has these sectors in place and some of the enterprises involved are ranked at international leading levels.
As the center of Shanghai's layout of biomedical industries, Zhangjiang is a cradle of innovations in the biotechnology and pharmaceutical industries.
Seven out of the world's top 10 pharmaceutical enterprises have set their regional headquarters or R&D centers in Zhangjiang, including Roche, Novartis and Pfizer.
It is noteworthy that a batch of entrepreneurial teams in Zhangjiang equipped with leading scientists, globalized R&D teams and top level venture capital have shifted from "licensing in" drugs from overseas biomedical companies to "licensing out" patented drugs to them. Exports of home-made drugs have been increasing year by year.
As a new highlight of the 4th CIIE, the biomedicine subsection will occupy 2,500 square meters in Hall 7.1 of the National Exhibition and Convention Center (Shanghai) and will feature new biological products and therapies as well as research and development platforms and bio technologies like biochips and enzyme engineering.
"The new subsection to display products of global biomedical companies will accelerate trade, cooperation and industrial exchanges. It will also inform domestic market players of cutting-edge technologies and industrial updates, helping the industry to develop on a large international scale with clusters," Lou said.
Applications for the 4th CIIE's Medical Equipment and Healthcare Products exhibition area keep rolling in.
Statistic showed that 138 companies, including 64 Fortune 500 companies and industrial leaders, have signed up.
Sources: CIIE Bureau, China Daily, english.pudong.gov.cn
The China International Import Expo Bureau (hereinafter referred to as the "CIIE Bureau") cites or reposts media reports for non-commercial purposes to facilitate information sharing. Such actions do not constitute an endorsement of the accuracy, authenticity, or legality of the original content, nor do they reflect the official stance of the CIIE Bureau. All copyrights and legal responsibilities for the reposted content remain with the original publishers and authors.
If any individual or entity believes that content shared on this website infringes their legitimate rights and interests, please promptly notify us in writing, providing detailed explanations, supporting documentation, and rationale. Upon receiving such materials, we will promptly remove or rectify the disputed content or take other appropriate measures.
Reposted or cited information may be time-sensitive. Users are advised to exercise independent judgment regarding the accuracy and completeness of the content. The CIIE Bureau shall not be liable for any direct, indirect, incidental, consequential, special, punitive, or exemplary damages arising from the use of or inability to use the information or links provided on this website.。
The CIIE Bureau respects intellectual property rights and is committed to delivering high-quality content services within a lawful and compliant framework.